Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 155,492 - -
Change - -20.69% -0.18% 2.67% 11.05% -28.63% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 163,560 160,947 157,071
Change - -20.41% 0.28% 1.92% 9.66% -26.41% -1.6% -2.41%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 22.3x 19.1x 16.4x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.14x 3.01x 2.81x
PEG - -36.9x -2x 0x -0.7x 3x 1.1x 1x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.09x 2.84x 2.65x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 3.25x 2.94x 2.68x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 12.1x 11x 9.86x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 14x 12.4x 11x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 18.9x 17.1x 15.1x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 5.3% 5.86% 6.61%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.549 2.718 2.858
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.86% 3.05% 3.2%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.997 4.681 5.438
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 63.8% 58.1% 52.6%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,262 54,740 58,591
EBITDA 1 12,815 12,485 10,188 10,635 11,735 13,500 14,687 15,938
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,661 13,022 14,302
Net income 1 7,071 6,933 5,723 13,402 6,524 6,923 8,285 9,226
Net Debt 1 7,801 6,891 7,783 6,509 4,407 8,068 5,455 1,580
Reference price 2 140.74 109.79 110.07 113.11 125.29 89.27 89.27 89.27
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,741,813 - -
Announcement Date 26/1/22 25/1/23 24/1/24 22/1/25 22/1/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
22x3.32x12.36x2.86% 155B
17.99x3.16x11.14x3.74% 102B
16.81x0.19x11.89x0.78% 58.81B
32.32x7.84x20.51x1.24% 52.82B
37.54x2.99x10.27x2.56% 41.51B
37.06x1.36x11.95x0.21% 32.69B
30.28x5.4x17.21x-.--% 28.6B
42.5x7.43x26.82x0.25% 25.27B
47.92x6.43x20.66x0.45% 20.99B
22.96x3.36x12.09x1.26% 20.34B
Average 30.74x 4.15x 15.49x 1.34% 53.75B
Weighted average by Cap. 26.26x 3.67x 13.94x 2.03%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. Valuation Abbott Laboratories